Literature DB >> 43285

Mannose-sensitive stimulation of human leukocyte chemiluminescence by Escherichia coli.

D F Mangan, I S Snyder.   

Abstract

Escherichia coli organisms with mannose-sensitive adherence factors (adhesins) are known to associate with human peripheral leukocytes (WBCs) in vitro in the absence of serum. To determine whether the WBC respiratory burst is activated during the interaction with E. coli, WBC chemiluminescence was measured. E. coli with mannose-sensitive adhesins stimulated a sharp burst of chemiluminescence which peaked 15 to 30 min after the bacteria and WBCs were mixed. Stimulation of chemiluminescence could be abrogated by including 10 mM alpha-methyl-D-mannoside in the test suspension. The addition of alpha-methyl-D-mannoside up to 20 min after the E. coli and WBCs were combined caused a rapid decrease in chemiluminescence. E. coli stimulation of chemiluminescence could not be inhibited by pretreating the WBCs with purified type 1 pili (fimbriae). E. coli lacking mannose-sensitive adhesins failed to stimulate chemiluminescence. The results emphasize the importance of mannose-sensitive adhesins in the association of E. coli with WBCs and suggest that the E. coli-WBC interaction system may be a useful tool for studying the mechanisms involved in the activation of the respiratory burst during phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43285      PMCID: PMC414721          DOI: 10.1128/iai.26.3.1014-1019.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Metabolic basis of phagocytic activity.

Authors:  M L KARNOVSKY
Journal:  Physiol Rev       Date:  1962-01       Impact factor: 37.312

2.  Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.

Authors:  S J Klebanoff
Journal:  Semin Hematol       Date:  1975-04       Impact factor: 3.851

3.  Subcellular localization of the superoxide-forming enzyme in human neutrophils.

Authors:  B Dewald; M Baggiolini; J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

4.  Isolation of a mannose-specific lectin from Escherichia coli and its role in the adherence of the bacteria to epithelial cells.

Authors:  Y Eshdat; I Ofek; Y Yashouv-Gan; N Sharon; D Mirelman
Journal:  Biochem Biophys Res Commun       Date:  1978-12-29       Impact factor: 3.575

5.  Mannose residues on phagocytes as receptors for the attachment of Escherichia coli and Salmonella typhi.

Authors:  Z Bar-Shavit; I Ofek; R Goldman; D Mirelman; N Sharon
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

6.  Reversible metabolic stimulation of polymorphonuclear leukocytes and macrophages by concanavalin A.

Authors:  D Romeo; G Zabucchi; F Rossi
Journal:  Nat New Biol       Date:  1973-05-23

7.  The superoxide anion and singlet molecular oxygen: their role in the microbicidal activity of the polymorphonuclear leukocyte.

Authors:  R C Allen; S J Yevich; R W Orth; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

8.  Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.

Authors:  I M Goldstein; D Roos; H B Kaplan; G Weissmann
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Effect of pili on susceptibility of Escherichia coli to phagocytosis.

Authors:  F J Silverblatt; J S Dreyer; S Schauer
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

10.  Evidence that the superoxide-generating system of human leukocytes is associated with the cell surface.

Authors:  I M Goldstein; M Cerqueira; S Lind; H B Kaplan
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

View more
  15 in total

1.  Histoplasma capsulatum fails to trigger release of superoxide from macrophages.

Authors:  L G Eissenberg; W E Goldman
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 2.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  D P Speert; F Eftekhar; M L Puterman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.

Authors:  E Blumenstock; K Jann
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes.

Authors:  P Robinson; D Wakefield; S N Breit; J F Easter; R Penny
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli.

Authors:  M B Goetz; F J Silverblatt
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Cooperative complement- and bacterial lectin-initiated bactericidal activity of polymorphonuclear leukocytes.

Authors:  C Kurashima; A L Sandberg; J O Cisar; L L Mudrick
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Enhancement of mannose-mediated stimulation of human granulocytes by type 1 fimbriae aggregated with antibodies on Escherichia coli surfaces.

Authors:  A Perry; I Ofek; F J Silverblatt
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

Review 9.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

10.  Effect of piliation on interactions of Haemophilus influenzae type b with human polymorphonuclear leukocytes.

Authors:  M F Tosi; D C Anderson; J Barrish; E O Mason; S L Kaplan
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.